What if the light around us could be redesigned to support the nervous system instead of working against it?

In this episode of Entrepreneur Rx, host John Shufeldt sits down with Nina Sharp, PhD, founder of Allevalux, to discuss her journey as a lighting scientist, professor, migraine patient, and entrepreneur. Nina shares how her background in architecture, engineering, human-building interaction, and light-health research led her to study the impact of lighting on sleep, mood, cognitive performance, and neurological comfort.

The conversation explores the problem Allevalux is working to solve: photophobia, or painful light sensitivity, which affects many people with migraine, dry eye, concussion, and neurodivergent conditions. Nina explains why common workarounds, such as sunglasses or colored lamps, do not fully solve the issue, and why she believes the better answer is to fix the light itself.

John and Nina also discuss Allevalux’s clinically validated, patent-pending lighting technology, which transforms everyday white light into a neuro-optimized environment designed to reduce visual discomfort, ease migraine symptoms, and support clearer, calmer experiences within minutes. Allevalux is designed to integrate into healthcare, workplace, and educational settings, creating environments that work in harmony with the nervous system.

Beyond the technology, the episode covers what it takes to create a new category, educate the market, build trust through clinical data, and move from scientific research to real-world commercialization. Nina also shares advice for founders, especially female founders, on understanding customers, staying flexible, learning from failure, and building technology that can make people healthier, happier, and better supported in everyday life.

About Nina Sharp, PhD: Leading Allevalux with visionary passion, Dr. Nina Sharp is dedicated to pushing the boundaries of lighting innovation. As a scientist and entrepreneur, she merges cutting-edge research with real-world applications, turning complex scientific discoveries into transformative solutions. With a deep commitment to human-centric design, she is redefining the role of lighting in health and well-being. At Allevalux, Nina drives innovation, strategy, and impact, ensuring that technology not only advances but also improves lives. Her leadership is fueled by a relentless pursuit of breakthrough solutions, making Allevalux a pioneer in the future of intelligent lighting.

About Allevalux: Allevalux is pioneering a new category of neuro-optimized environments, transforming everyday light into an active layer of neurological comfort. Its clinically validated, patent-pending lighting technology is engineered to reduce photophobia, ease migraine symptoms, and support clearer, calmer human experiences within minutes. Designed to integrate seamlessly into healthcare, workplace, and educational settings, Allevalux brings together neuroscience and precision engineering to create environments that work in harmony with the nervous system, not against it.

About Xcellerant Ventures: Xcellerant Ventures is a venture capital firm that invests in innovative companies across healthcare, technology, defense, and other emerging industries. Through multiple funds and investment vehicles, including the Jetstream Venture Fund, Xcellerant partners with visionary founders, provides strategic guidance, and helps connect investors with opportunities in the private markets.